[Turner-syndrome and psychosis: a case report and brief review of the literature].
OBJECTIVE
Turner syndrome encompasses several chromosomal abnormalities and includes a typical clinical manifestation. While common somatic symptoms are often described, neuropsychiatric alterations are rare and not frequently mentioned in the literature.


METHODS
In this paper, we report on a subject with Turner syndrome who also showed psychotic symptoms.


CONCLUSIONS
The theoretical background and the relevance of this observation are discussed. Furthermore, this article briefly reviews existing reports on Turner syndrome and psychosis and presents neuropsychiatric changes in patients with Turner syndrome.
Wustmann
Tobias
T
Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Martin-Luther-Universität Halle-Wittenberg, Halle / Saale. tobias.wustmann@medizin.uni-halle.de
Preuss
Ulrich W
UW
D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D002869:Chromosome Aberrations; D015283:Citalopram / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005260:Female; D006212:Hallucinations / Q000188:drug therapy / Q000235:genetics / Q000523:psychology; D006801:Humans; D008875:Middle Aged; D000077152:Olanzapine; D010353:Patient Education as Topic; D011613:Psychotherapy; D011618:Psychotic Disorders / Q000188:drug therapy / Q000235:genetics* / Q000523:psychology; D018967:Risperidone / Q000627:therapeutic use; D014424:Turner Syndrome / Q000235:genetics* / Q000523:psychology
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D015283:Citalopram; D001569:Benzodiazepines; D018967:Risperidone; D000077152:Olanzapine